Let’s cut to the point: the transition to value-based care isn’t theoretical anymore. It’s operational. ACO REACH ends December 31, 2026. The LEAD model launches January 1, 2027. And if your marketing team is still building campaigns around procedure volumes and service line growth, you’re solving for a reimbursement model that’s disappearing.
This isn’t about being early. You’re already late.
The Misalignment Problem
Here’s what keeps coming up in conversations with healthcare CMOs: their organizations have made massive operational shifts—care coordination platforms, risk-based contracts, population health infrastructure but the marketing still talks like it’s 2012.
You’re messaging elective procedures while your finance team is managing capitated risk. You’re promoting new facilities while your clinical team is trying to reduce avoidable utilization. The strategy and the story aren’t connected.
That gap isn’t just confusing. It’s expensive. Because if patients, referring physicians, and community partners don’t understand your value-based model, they can’t engage with it.
What Value-Based Care Actually Demands from Marketing
Value-based care flips the incentive structure. Instead of rewarding activity, it rewards outcomes. That means marketing needs to shift from transactional messaging to transformational engagement.
Here’s what that looks like in practice:
- Stop promoting volumes. Start promoting outcomes.
- Instead of “We perform 10,000 surgeries a year,” try “98% of our joint replacement patients return to independent living within 90 days.” The story isn’t about what you do, it’s about what happens because of what you do.
- Stop treating prevention as a sidebar. Make it the lead.
- VBC prioritizes prevention, early intervention, and chronic disease management. If your campaigns still focus on acute care heroics, you’re reinforcing the wrong behavior. Show how screenings, care coordination, and patient engagement prevent crises.
- Stop siloing equity. Integrate it into every message.
Health equity isn’t a CSR initiative under VBC—it’s a financial imperative. ACO REACH and the new LEAD model both include explicit equity benchmarks. Your marketing should reflect that community health, access, and social determinants aren’t side projects—they’re core strategy.
How the GiG Model Anchors VBC Marketing
This is where ab+a’s GiG Model—Grow, Impact, Good—becomes essential.
Grow means precision targeting. You’re not chasing everyone. You’re identifying high-risk populations, closing care gaps, and engaging patients in preventive touchpoints that improve outcomes and reduce costs.
Impact means flawless execution. Strategy doesn’t matter if it dies in approvals or launches six months late. VBC moves fast. Your marketing must match that speed with AI-enhanced workflows, real-time performance tracking, and coordinated omnichannel delivery.
Good means showing how your purpose drives performance. Community benefit, equity work, and social determinants aren’t separate from VBC—they’re what makes it work. When you make that visible, you build trust. And trust drives loyalty, engagement, and outcomes.
The Bottom Line
The market has moved. ACO models now serve over 13 million Medicare beneficiaries. CMS has made clear that value-based care is the path forward, not an experiment.
Your clinical teams are already there. Your finance teams are managing the risk. The question is: when does your marketing catch up?
You don’t need a rebrand. You need a reframe—one that aligns your message with the model that’s paying the bills and shaping the future.
